NAP
BRLI

New Amsterdam Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

New Amsterdam Partners’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-137,335
Closed -$4.84M – 139
2015
Q1 		$4.84M Buy
+137,335
New +$4.65M 0.39% 61

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

New Amsterdam Partners's BRLI Position: Q2 2015 in Review

New Amsterdam Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 137,335 shares — an estimated $4.84M sold.

New Amsterdam Partners first reported a position in BRLI in Q1 2015 and held it in 1 quarter. The position peaked at $4.84M in Q1 2015. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • New Amsterdam Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • New Amsterdam Partners sold 137,335 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $4.84M.
  • New Amsterdam Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2015 and held it in 1 quarter.
  • New Amsterdam Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $4.84M in Q1 2015.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on New Amsterdam Partners's 13F filing for Q2 2015, filed 7 Aug 2015.